Thrombus aspiration during primary percutaneous coronary intervention associated with reduced platelet activation

Muslum Sahin1, Goksel Acar, Mehmet E Kalkan

  • 1Department of Cardiology, Kartal Kosuyolu High Specialty Education and Research Hospital, Istanbul, Turkey. E-mail. sahinm78@yahoo.com.

Saudi Medical Journal
|July 30, 2015
PubMed

Insights

Thrombectomy during primary percutaneous coronary intervention for ST-elevation myocardial infarction reduced platelet activity. This procedure effectively removed thrombi, impacting platelet count and mean platelet volume post-intervention.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Hematology

Background:

  • ST-segment elevation myocardial infarction (STEMI) is a critical condition requiring immediate reperfusion.
  • Primary percutaneous coronary intervention (PPCI) is the standard treatment for STEMI.
  • The role of thrombectomy in modulating platelet function during PPCI requires further elucidation.

Purpose of the Study:

  • To investigate the impact of thrombectomy on platelet function in STEMI patients undergoing PPCI.
  • To compare platelet count and mean platelet volume (MPV) between patients who underwent thrombus aspiration (TA) and those who did not.

Main Methods:

  • Retrospective analysis of 413 STEMI patients undergoing PPCI.
  • Patients were categorized into thrombus aspiration (TA) and non-TA groups.
  • Platelet count and MPV were measured at baseline and at 24, 48, and 72 hours post-PPCI.

Main Results:

  • Baseline platelet count was higher in the TA group (p=0.002).
  • Platelet count remained elevated in the TA group at 24 hours post-PPCI (p=0.02).
  • Mean platelet volume (MPV) was higher in the non-TA group at 48 and 72 hours post-PPCI (p=0.04).

Conclusions:

  • Thrombectomy in STEMI patients undergoing PPCI appears to reduce platelet activity.
  • The removal of thrombi by thrombectomy influences platelet parameters.
  • Findings suggest thrombectomy may modulate thrombotic potential post-reperfusion.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
672
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
586